Reducing Sedentary Time in Patients With Heart Failure

Heart Failure Clinical Trial

— Rest-HF  

Official title:

Reducing Sedentary Time in Patients With Heart Failure

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02911493
• Other study ID #: 16-1330
• Status: Completed
• Phase: N/A
• Start date: September 2016
• Est. completion date: April 2019

Study information

• Verified date: August 2019
• Source: University of Colorado, Denver
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To determine the change in sedentary time and number of steps/day for older patients with heart failure at risk for mobility disability who receive a program to decrease sedentary behavior versus a standard program to increase exercise.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: April 2019
• Est. primary completion date: April 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years to 100 Years

Eligibility

Inclusion Criteria:

• NYHA II-IV,

• Age = 65,

• SPPB score of > 4 and = 10 of 12,

• and deemed (by 1° cardiologist) to be at maximal tolerated dose of heart failure medication (ACE-inhibitor (ACE-I)/angiotensin receptor blocker and beta blocker (BB) for patients with HF with reduced ejection fraction (HFrEF), and

• blood pressure controlled for HF with preserved ejection fraction (HFpEF) according to the American Heart Failure Association HF guidelines.

Exclusion Criteria:

• Patients requiring medication titration such as ACE-I or BB, (will return to their cardiologist and be eligible after 3 months of stable medication.)

• Oxygen dependent lung disease,

• Orthopedic or neurologic disease that severely limits mobility,

• Active cancer diagnosis except non-melanoma skin cancer,

• Geriatric Depression Scale (GDS) score of = 9 ,

• Limited life-expectancy of <6 months,

• Known dementia or disease that effects ability to learn/follow directions, or

• Failed MiniCog test.

Related Conditions & MeSH terms

• Heart Failure

Intervention

Behavioral:
• Reducing Sedentary Behavior
The experimental group will wear an activPAL and have counseling sessions that use the Health Belief Model and Motivational Interviewing strategies to reduce sedentary time.
• Physical Activity Group
The Active Comparative group will wear an activPAL and have counseling sessions that use the Health Belief Model and Motivational Interviewing strategies to increase exercise time.

Locations

Country	Name	City	State
United States	University of Colorado University	Aurora	Colorado

Sponsors (1)

Lead Sponsor	Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Subjects that are more active than Control.		Monthly for 3 months